BEIJING, Sept. 12, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it received a staff determination letter (the "Letter") from the Nasdaq Stock Market LLC ("Nasdaq"), dated September 11, 2025, notifying that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the "Bid Price R
[ 메디채널 황정호 기자 ] Streamlined Board to Support the Company's Growth and Governance Objectives BEIJING, Sept. 12, 2025 -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the appointment of two new independent directors as part of a comprehensive board restructuring initiative. The Board of Directors (the "Board") approved the appointments during a meeting held earlier today, implementing a streamlined governance structure that reduces the Board from seven to five members.&nb
BEIJING, Sept. 12, 2025 -- The 2025 Asian Rowing U-19&U-23 Championships concluded on August 31 in Shenyang, northeast China's Liaoning Province. Hosted by the Asian Rowing Federation and jointly organized by the Chinese Rowing Association and the Shenyang sports bureau, the event featured two age categories: U19 (under 19 years old) and U23 (under 23 years old). A total of 258 athletes from 15 countries and regions, including Indonesia, the Philippines, Japan, the Republic of Korea, and Thailand, competed in 24 medal events. As the only Asian city to host the
SHANGHAI, Sept. 12, 2025 -- Pulnovo Medical, a globally recognized leader in medical devices for pulmonary hypertension (PH) and heart failure (HF), is proud to announce that its PADN catheter and generator has received two Investigational Device Exemption (IDE) approvals—HDE study approved for patients with Group I PH patients, PMA study approved for patients with Group II PH patients, with CMS full coverage approval, paving the way for upcoming clinical trials in the United States. Following the FDA's BDD designation granted in 2021 for Groups I, II, and IV, the newly obtained IDE ap
[ 메디채널 황정호 기자 ] East-West Marketing Leaders Unite as AI Revolution Transforms Hong Kong HONG KONG, Sept. 12, 2025 -- Artificial Intelligence (AI) is transforming our lives and business models at an unprecedented pace. A recent local bank survey shows that over 70% of customers use generative AI daily, and businesses are actively embracing AI to enhance customer experiences, optimise data analytics, and explore new avenues for growth. As Hong Kong's largest digital marketing community, IAB Hong Kong announces that its annual flagship event "C25" will take place on 24 Septem
[ 메디채널 황정호 기자 ] Singapore Finternet pioneer backs global cycling showcase, spotlighting trust, financial literacy, and inclusive growth across Asia and Africa SINGAPORE, Sept. 12, 2025 -- Less than 18 months after its founding on 25 April 2024, Embed Financial Group Holdings (EFGH) has claimed the naming rights to one of the world's most prestigious cycling events, becoming Title Sponsor of the Tour de France EFGH Singapore Criterium 2025. The event, to be held on 1-2 November 2025, will now carry the name Tour de France EFGH Singapore Criterium 2025. For a company jus
BEIJING, Sept. 12, 2025 -- Alongside the debut of 2025 China (Shenyang) Rowing Development Index recently, Shenyang decoded how a traditional industrial base leveraged the "sport+" mode to cultivate new urban hallmark and economic boosters. On September 5, the China (Shenyang) Rowing Development Index Report (2025) was released there, saying that rowing in the city has undergone leap-forward development thanks to the Hun River-based resources and preferential policies. In recent years, a series of high-level rowing competitions were staged in Shenyang where row
스톡홀름, 2025년 9월 12일 -- 국제건선협회연맹(국제 건선 협회 연맹(International Federation of Psoriasis Associations, IFPA)이 오는 뉴욕 제80차 UN 총회(UNGA 80)에서 건선 질환을 조명한다고 밝혔다. 이번 총회에서는 세계 각국 지도자들이 비감염성 질환(NCD), 정신 건강 및 웰빙과 관련하여 새로운 정치적 선언문을 채택할 예정이다. 주요 내용: 전 세계 약 6000만 명이 건선 질환을 앓고 있으며, 이는 피부, 관절, 기타 장기를 침범하는 심각하고 평생 지속되는 비감염성 질환이다. 건선은 또한 당뇨병, 비만, 심혈관 질환 및 우울증의 위험을 높인다. 2014년 세계보건기구(WHO)가 건선을 주요 공중 보건 문제로 인정한 결의안을 채택했음에도 불구하고, 관련 진행은 더디게 이루어지고 있다. 이에 IFPA는 새로운 글로벌 차원의 노력을 촉구하고 있다. IFPA 대표단은 UN 고위급 NCD 회의에 참석해 건선 질환을 글로벌•국가 보건 정책에 포함시키고, 특히 실제 경험을 정책 결정의 중심에 두도록 촉구
LONDON, Sept. 12, 2025 -- Today's heroes aren't just found in capes or costumes, they're in classrooms, communities, and everyday moments. While many children still associate heroism with beloved Disney characters (44%), a new study exploring modern-day heroism polling 2,000 UK parents and children aged 5–11 reveals a broader shift: Brits are just as likely to see heroic qualities in real people around them as they are in films and TV (66%). When asked to identify the most important traits of a hero, children chose bravery (57%), helping others (44%
TAIPEI and TOKYO, Sept. 12, 2025 -- The Taiwan Stock Exchange (TWSE) today announced the listing of Japan's first exchange-traded fund (ETF) investing solely in Taiwan equities on the Tokyo Stock Exchange (TSE). The listing marks a significant milestone in cross-border capital market collaboration and enhances worldwide investor access to Taiwan's dynamic technology sector. TWSE President Edith Lee attended the listing ceremony in Tokyo for the ETF, which is issued by Daiwa Asset Management. The fund tracks Cathay SITE's 00881 Taiwan Technology Leaders ETF and represents the fi